EugenieS.KleinermanMD

Adolescent Medicine

Professor of Pediatrics, University Tex Houston

Dr. Kleinerman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

CD103cDC1 Dendritic Cell Vaccine Therapy for Osteosarcoma Lung Metastases.
Yuanzheng Yang, Yifan Zhou, Jian Wang, You Zhou, Stephanie S Watowich
Cancers. 2024-09-24
Adolescent and young adult Hodgkin lymphoma patients at risk for subcutaneous fat gain during early cancer treatment: a brief report.
Savannah Victoria Wooten, Behrang Amini, Michael Roth, Cheuk Hong Leung, Jian Wang
Leukemia & Lymphoma. 2024-01-01
Poor Sit-to-Stand Performance in Adolescent and Young Adult Patients with Sarcoma.
Savannah V Wooten, Behrang Amini, J Andrew Livingston, Michelle A T Hildebrandt, Joya Chandra
Journal of Adolescent and Young Adult Oncology. 2023-12-01

Developing New Tools to Fight CancerOctober 17th, 2022
Straight to the Lungs: Inhaled Chemo Lessens Collateral DamageJune 11th, 2019
Program Spotlight: University of Puerto Rico and MD Anderson Partnership Welcomes Its First Graduates, Dedicated to Researching Cancer Health DisparitiesOctober 1st, 2014
Join now to see all

Vasculogenesis In Ewing'S Sarcoma: Implications For TherapyNational Cancer Institute2008–2011
Liposome And Polycationic Gene Therapy For OsteosarcomaNational Cancer Institute2000–2010
Vasculogenesis In Ewing'S Sarcoma: Implications For TherapyNational Cancer Institute2007
Vasculogenesis In Ewing'S Sarcoma: UseintherapyNational Cancer Institute2005–2006
Vacdxr With Or Without Immther For Newly Diagnosed High Risk Ewing'S SarcomaNational Center For Research Resources2005
Vacdxr With Or Without Immther For Ewing'S SarcomaNational Center For Research Resources2004
Vasculogenesis In Ewing'S Sarcoma: Implications For TherNational Cancer Institute2004
Vacdxr W/ Or W/Out Immther For Newly Diagnosed High Risk Ewings SarcomaNational Center For Research Resources2000–2002
Chemo/Immunotherapy For High Risk Ewings SarcomaNational Cancer Institute1999–2001
Vacdxr W/ Or W/Out Immther For Diagnosed High Risk Ewings SarcomaNational Center For Research Resources1999
Liposome Therapy--A Potential Adjuvant For OsteosarcomaNational Cancer Institute1990–1999
Efficacy Of IL1 And Etoposide In Relapsed OsteosarcomaNational Cancer Institute1995
Liposome Therapy--A Potential Adjuvant For ChildhoodNational Cancer Institute1986–1989